Bristol-Myers Squibb and Adnexus Therapeutics in Collaboration for Cancer Biologics
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 82 (Table of Contents)
Published: 7 Apr-2007
DOI: 10.3833/pdr.v2007.i82.357 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Bristol-Myers Squibb and Adnexus Therapeutics formed a global strategic partnership to discover, develop and commercialize Adnectin(TM)-based therapeutics for oncology-related targets...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS